PD2i Analysis of Heart Rate Variability in Competitive Sports
PACA
1 other identifier
observational
90
1 country
1
Brief Summary
This is a double blind observational analysis of changes in heart rate variability using PD2i analyser in competitive athletes during strenuous exercise and competition.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2010
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2010
CompletedFirst Submitted
Initial submission to the registry
November 24, 2010
CompletedFirst Posted
Study publicly available on registry
November 29, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2011
CompletedApril 12, 2012
April 1, 2012
1 month
November 24, 2010
April 10, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in PD2i following strenuous exercise bout of 45 minutes
PD2i analysis of HRV measured before and after strenuous exercise in each sport. The change from baseline will be correlated to return to resting heart rate.
Baseline at zero minutes and within 60 minutes of completion of strenuous exercise bout.
Secondary Outcomes (1)
Change in PD2i following an injury during competitive sports.
Baseline PD2i at zero and within 60 minutes of cessation of exercise bout.
Study Arms (8)
Male basketball players
Female basketball players
Baseball players
Softball players
Football players
Female vollyball players
Male soccer players
Female soccer players
Interventions
Analysis of heart rate variability from a standard digital ECG for 6-12 minutes
Eligibility Criteria
College athletes on competitive teams.
You may qualify if:
- Age \>18 years, as determined by birth date given on participation form.
- Actively involved in competitive athletics
- Able to give informed consent
You may not qualify if:
- Any known prior autonomic dysfunction
- History of seizures or taking anti-seizure medication
- Known learning disability or attention deficit disorder
- Chronic heart conditions such as arrhythmias or valvular disease
- History of diabetes mellitus
- Taking any prescription stimulants such as Ritalin, Focalin, etc.
- Use of any performance-enhancing drugs
- Any deviation from normal found on the pre-participation physical exam such as the presence of a murmur or hypertension.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Mississippi Medical Centerlead
- Vicor Technologies, Inc.collaborator
Study Sites (1)
University of Mississippi Medical Center
Jackson, Mississippi, 39216, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Steve A Watts, MD
University of Mississippi Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 24, 2010
First Posted
November 29, 2010
Study Start
October 1, 2010
Primary Completion
November 1, 2010
Study Completion
July 1, 2011
Last Updated
April 12, 2012
Record last verified: 2012-04